Avalanche Biotechnologies, Inc. (Nasdaq: AAVL) and Annapurna Therapeutics SAS, a privately held biopharmaceutical company, today announced that they have entered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE